Dr. Kishore Kumar Shil – Diabetes, Thyroid, Hormone Specialist, Khulna
Dr. Kishore Kumar Shil is a Consultant of Endocrinology at Khulna Medical College & Hospital, Khulna, with over 12 years of distinguished clinical, academic, and systemic endocrine experience. As an eminent Endocrinologist and Medicine Specialist, he provides expert care for severe and exceedingly rare metabolic conditions, primarily focusing on pancreatic neuroendocrine tumors (pNETs) such as insulinomas, gastrinomas (Zollinger-Ellison Syndrome), glucagonomas, VIPomas, and somatostatinomas. Patients seeking expert endocrine evaluation receive evidence-based treatments tailored to halt tumor progression, manage acute metabolic crises, and restore multi-organ hormonal balance. His medical practice combines high-precision endocrine diagnostics with individualized, systemic patient care plans enriched by his advanced training at the Mayo Clinic, USA.
Professional Biography
Dr. Kishore Kumar Shil completed his MBBS degree, establishing a comprehensive clinical foundation. He entered the prestigious BCS (Health) cadre and pursued highly rigorous postgraduate specializations, earning the highest clinical degree, Doctor of Medicine (MD) in Endocrinology, alongside his FCPS (Medicine, Final Part). Validating his unparalleled expertise on a global scale, he achieved the prestigious Member of the American Association of Clinical Endocrinology (MACE, USA) and Member of the American College of Physicians (MACP, USA) credentials. What truly sets Dr. Shil apart is his Advanced Training in Endocrinology from the world-renowned Mayo Clinic, USA, providing him with master-class exposure to some of the rarest endocrine pathologies on the planet. Finding the best Endocrinologist in Khulna leads patients to rely on his 12+ years of global academic leadership and specialized clinical expertise.
His primary clinical focus includes continuous glucose monitoring and targeted therapies for insulinoma-induced hypoglycemia, specialized somatostatin analogue therapies for VIPomas and glucagonomas, high-dose proton pump inhibitor protocols and tumor localization for gastrinomas, and complex hormonal suppression for somatostatinomas. His diagnostic framework incorporates advanced 72-hour fasting tests, secretin stimulation tests, endoscopic ultrasounds (EUS), highly specific gut hormone panels, and comprehensive risk stratification to formulate effective, long-term metabolic strategies.
At-a-Glance Profile Card
| Profile Field | Details |
| Full Name | Dr. Kishore Kumar Shil |
| Primary Specialty | Endocrinology (Diabetes, Thyroid & Hormone) |
| Secondary Specialties | Pancreatic Neuroendocrine Tumors (pNETs) & Internal Medicine |
| Designation | Consultant (Endocrinology) |
| Workplace | Khulna Medical College & Hospital, Khulna |
| Total Experience | 12+ Years |
| Location | Khulna, Bangladesh |
Qualifications & Education
MBBS – Bachelor of Medicine and Bachelor of Surgery
MD (Endocrinology) – Doctor of Medicine in Endocrinology
FCPS (Medicine, FP) – Fellow of the College of Physicians and Surgeons (Final Part)
MACE (USA) – Member of the American Association of Clinical Endocrinology
MACP (USA) – Member of the American College of Physicians
Advanced Training – Endocrinology (Mayo Clinic, USA)
Designation & Workplace
Designation: Consultant (Endocrinology)
Workplace: Department of Endocrinology, Khulna Medical College & Hospital, Khulna
Diseases Treated
Insulinoma requires intensive hypoglycemia management and surgical tumor localization.
Gastrinoma (Zollinger-Ellison Syndrome) demands severe gastric acid suppression.
Glucagonoma requires specialized treatment for necrolytic migratory erythema and diabetes.
VIPoma syndrome needs urgent fluid resuscitation and somatostatin analogue therapy.
Somatostatinoma demands complex management of diabetes, gallstones, and fat malabsorption.
Type 1 diabetes requires lifelong insulin therapy and intensive glucose monitoring.
Type 2 diabetes demands lifestyle modification, oral hypoglycemics, and insulin management.
Hashimoto thyroiditis needs vigilant monitoring and synthetic thyroid hormone replacement.
Graves' disease requires anti-thyroid medications or radioactive iodine.
Cushing syndrome demands specialized diagnostic testing and cortisol-lowering therapies.
Pituitary adenomas demand prolactin or growth hormone-targeted medications.
Addison's disease requires life-saving lifelong corticosteroid replacement.
Polycystic ovary syndrome (PCOS) requires hormonal balancing and metabolic care.
Primary hyperparathyroidism needs calcium monitoring and metabolic care.
Osteoporosis requires bone density evaluation and anti-resorptive medications.
Clinical Specialties & Treatment Areas
Rare Pancreatic Endocrine Tumors: Highly specialized, Mayo Clinic-guided protocols for diagnosing and managing rare tumors that secrete massive amounts of hormones (Insulin, Gastrin, Glucagon, VIP).
Advanced Hypoglycemia & GI Endocrinology: Precision management for life-threatening low blood sugars (hypoglycemia) not caused by diabetes drugs, and severe recurrent peptic ulcers caused by hormonal imbalances.
Global Standard Diabetology & Thyroidology: Comprehensive management of Type 1 and Type 2 diabetes and complex thyroid disorders, leveraging 12 years of dual expertise in general medicine and endocrinology.
Advanced Procedure Breakdown
72-Hour Fasting Protocol for Insulinoma
Diagnosing an insulinoma (a tumor that overproduces insulin) requires a highly supervised, in-hospital 72-hour fasting test. Dr. Shil continuously monitors the patient's blood glucose, insulin, C-peptide, and proinsulin levels. If the patient develops severe hypoglycemia but their insulin levels remain inappropriately high, an insulinoma is definitively diagnosed.
Secretin Stimulation Test for Gastrinoma
For patients with multiple, non-healing stomach ulcers, a Gastrinoma (Zollinger-Ellison Syndrome) is suspected. Dr. Shil administers an intravenous injection of the hormone secretin. In a healthy person, secretin suppresses gastrin. In a patient with a gastrinoma, gastrin levels will paradoxically skyrocket, confirming the diagnosis.
Somatostatin Analogue (Octreotide) Therapy
For highly symptomatic tumors like VIPomas (causing massive watery diarrhea) or Glucagonomas (causing severe skin rashes), Dr. Shil utilizes synthetic somatostatin analogues (like Octreotide injections). These powerful medications act as a "master off-switch," rapidly blocking the tumor from secreting its toxic levels of hormones and providing instant, life-saving symptom relief.
Condition-Specific Deep Dives
Insulinoma
A rare, usually benign tumor of the pancreas that continuously secretes insulin, regardless of the patient's blood sugar level. It causes extreme, life-threatening hypoglycemia (low blood sugar), especially when fasting or exercising. Patients often experience confusion, bizarre behavior, seizures, and even coma, frequently leading to misdiagnosis as a psychiatric or neurological disorder.
Gastrinoma (Zollinger-Ellison Syndrome)
A tumor in the pancreas or duodenum that secretes massive amounts of the hormone gastrin. Gastrin forces the stomach to produce extreme amounts of stomach acid. This acid literally burns through the stomach and intestinal lining, causing severe, recurrent, and bleeding peptic ulcers that do not respond to standard antacid treatments, accompanied by chronic diarrhea.
VIPoma & Glucagonoma
A VIPoma secretes Vasoactive Intestinal Peptide, causing "WDHA Syndrome" (Watery Diarrhea, Hypokalemia, and Achlorhydria). Patients can lose up to 10 liters of watery stool a day, leading to fatal dehydration. A Glucagonoma secretes glucagon, causing sudden-onset diabetes, deep vein thrombosis (DVT), and a highly specific, painful, blistering skin rash called Necrolytic Migratory Erythema (NME).
The Doctor’s Clinical Approach
Dr. Kishore Kumar Shil utilizes over 12 years of profound clinical wisdom, uniquely combining his internal medicine expertise with his world-class Mayo Clinic training. His philosophy emphasizes an exhaustive, detective-like diagnostic approach to unearth rare neuroendocrine tumors, prioritizing rapid symptomatic relief through targeted hormone blockers, and coordinating complex multidisciplinary surgical referrals.
Specialized Risk Factors
Emergency Callout: Immediate emergency medical evaluation is required if a patient experiences sudden, profound confusion, seizures, or loss of consciousness that immediately resolves after eating sugar (severe insulinoma hypoglycemia), begins vomiting large amounts of blood or passing black, tarry stools (bleeding gastrinoma ulcers), or suffers massive, uncontrollable watery diarrhea leading to severe weakness and heart palpitations (VIPoma crisis).
Certifications & Professional Memberships
Member, Bangladesh Medical and Dental Council (BMDC)
Member, American Association of Clinical Endocrinology (MACE, USA)
Member, American College of Physicians (MACP, USA)
Advanced Training Alumni, Mayo Clinic, USA
Patient Visit Preparation Checklist
Bring all prior blood test reports (especially fasting blood sugars during "spells" of confusion, Serum Gastrin, Glucagon, or VIP levels if available) and any Endoscopy or CT/MRI abdomen reports.
Maintain a complete list of current prescription medications, particularly high-dose antacids (PPIs) or any oral diabetic medications.
Keep a meticulous symptom diary noting exactly when confusion/fainting spells occur in relation to meals (crucial for insulinoma) or the volume of daily diarrhea.
Ensure a family member accompanies the patient, as severe hypoglycemic episodes can impair memory and cognitive function during the consultation.
Last Modified: October 25, 2026